Geneva Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.3M Sell
17,557
-494
-3% -$36.7K 0.02% 311
2017
Q1
$1.32M Buy
18,051
+438
+2% +$30.7K 0.02% 296
2016
Q4
$1.15M Buy
17,613
+167
+1% +$11.4K 0.02% 302
2016
Q3
$1.29M Sell
17,446
-50
-0.3% -$3.7K 0.02% 268
2016
Q2
$1.28M Sell
17,496
-1,680
-9% -$120K 0.03% 257
2016
Q1
$1.35M Buy
19,176
+1,416
+8% +$94.2K 0.03% 244
2015
Q4
$1.18M Buy
17,760
+470
+3% +$31.3K 0.02% 279
2015
Q3
$1.1M Sell
17,290
-28
-0.2% -$1.83K 0.02% 278
2015
Q2
$1.13M Sell
17,318
-512
-3% -$34.7K 0.02% 288
2015
Q1
$1.24M Sell
17,830
-2,045
-10% -$141K 0.02% 264
2014
Q4
$1.38M Sell
19,875
-3,972
-17% -$268K 0.03% 248
2014
Q3
$1.55M Buy
23,847
+1,936
+9% +$128K 0.03% 230
2014
Q2
$1.49M Buy
21,911
+111
+0.5% +$7.44K 0.03% 249
2014
Q1
$1.41M Buy
21,800
+7,900
+57% +$498K 0.03% 253
2013
Q4
$906K Buy
13,900
+577
+4% +$36.9K 0.02% 264
2013
Q3
$790K Sell
13,323
-361
-3% -$21.4K 0.02% 282
2013
Q2
$784K Buy
+13,684
New +$812K 0.02% 239

Other funds holding CL

Geneva Advisors's CL Position: Q2 2017 in Review

Geneva Advisors reduced its Colgate-Palmolive (CL) stake by 2.7% in Q2 2017, selling an estimated $36.7K and leaving 17,557 shares worth $1.3M. The position accounts for 0.02% of the portfolio, ranked #311.

Geneva Advisors first reported a position in CL in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.55M in Q3 2014. 1,370 funds tracked by Wall St. Rank hold CL as of Q2 2017.

  • Geneva Advisors held 17,557 shares of Colgate-Palmolive worth $1.3M as of Q2 2017.
  • Geneva Advisors sold 494 Colgate-Palmolive shares in Q2 2017, an estimated $36.7K.
  • Colgate-Palmolive made up 0.02% of Geneva Advisors's portfolio in Q2 2017, its #311 holding.
  • Geneva Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 17 quarters since.
  • Geneva Advisors's Colgate-Palmolive position peaked at $1.55M in Q3 2014.
  • 1,370 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.